Larry Mathis Financial Planning’s GSK GSK Stock Holding History
Bought
Maintained
Sold
Other funds holding GSK
Larry Mathis Financial Planning's GSK Position: Q3 2026 in Review
Larry Mathis Financial Planning reduced its GSK (GSK) stake by 7.9% in Q3 2026, selling an estimated $29.4K and leaving 6,742 shares worth $325K. The position accounts for 0.28% of the portfolio, ranked #72.
Larry Mathis Financial Planning first reported a position in GSK in Q4 2025 and has held it in 3 quarters since. The position peaked at $384K in Q2 2026. 993 funds tracked by Wall St. Rank hold GSK as of Q3 2026.
- Larry Mathis Financial Planning held 6,742 shares of GSK worth $325K as of Q3 2026.
- Larry Mathis Financial Planning sold 576 GSK shares in Q3 2026, an estimated $29.4K.
- GSK made up 0.28% of Larry Mathis Financial Planning's portfolio in Q3 2026, its #72 holding.
- Larry Mathis Financial Planning first reported a position in GSK in Q4 2025 and has held it in 3 quarters since.
- Larry Mathis Financial Planning's GSK position peaked at $384K in Q2 2026.
- 993 funds tracked by Wall St. Rank held GSK as of Q3 2026.
Based on Larry Mathis Financial Planning's 13F filing for Q3 2026, filed 26 Oct 2026.